Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma

• मुख्य लेखकों: A. G. Tolkushin (लेखक), V. A. Rogov (लेखक), D. A. Ivanov (लेखक), N. L. Pogudina (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Izdatelstvo OKI, 2019-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Objective. To determine the clinical and economic consequences of the drug mepolizumab in patients with severe bronchial asthma (SBA) and the ineff ectiveness of omalizumab. Methods. We conducted cost-eff ectiveness and budget impact analysis of the use of mepolizumab or omalizumab in omalizumab-ref...